Nordic study on innovation, development and production of vaccines

Important results from the project

The aim of the project was to produce a report on the potential for a deepened Nordic collaboration in vaccine development. The overall goal of such potential collaboration is stronger Nordic contribution to Europe´s resilience and to promote Nordic competitiveness in the development and manufacture of vaccines. The project has delivered a consolidated inventory of available capacity in vaccine production, clinical trials, supply chain and participation in European and international vaccine initiatives.

Expected long term effects

** Denna text är maskinöversatt ** The report contains an overview of the Nordic capacity in the vaccine production value chain; from preclinical development to clinical studies. The report also describes investments and ventures that are relevant to vaccine manufacturing in the Nordics, as well as selected EU initiatives and international initiatives. The report is expected to serve as a basis for continued planning of how the Nordic countries can cooperate in innovation, development and production of vaccines.

Approach and implementation

The project was led by RISE and was divided into three parts. 1) National mapping of capacity in vaccine development 2) compilation of selected EU initiatives and the Nordic countries´ involvement in these. 3) Compilation of capacities in development, production and clinical trials of vaccines, possible synergies and areas for cooperation in a joint report. Conclusions and suggestions were drawn during joint discussions, as well as using written feedback on documents during the course of the project.